Edwards Lifesciences Corp Investor and Analyst TAVR Q&A Session at TCT Transcript

Oct 25, 2023 / 01:00AM GMT
Mark Wilterding - Edwards Lifesciences Corporation - VP of IR

Excuse me. Hi, everybody. If you could just start taking your seats, please, we're going to get kicked off here in a second.

So as you're getting seated, I will just start in with the introduction. First off, thank you all for coming tonight. We really appreciate it, both online and in person. It's great to see such a great turnout. And we're excited about the session we have in front of you.

For the next 45 minutes or so, we'll be joined by a distinguished panel and our CEO, Bernard Zovighian, and looking forward to the discussion.

Before we get into it and before I introduce Bernard, I want to just flash up the forward-looking statements. Just note that management may be speaking and making some forward-looking statements. They do not undertake any obligation to update them after today. They're also available on our website, so please take a look there and familiarize yourself with them.

I should also mention that we'll be hosting our Q3 earnings event tomorrow. We'll also have another investor event on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot